180 related articles for article (PubMed ID: 1257911)
1. DES-transplacental teratogen-and possibly also carcinogen.
Ulfelder H
Teratology; 1976 Feb; 13(1):101-3. PubMed ID: 1257911
[No Abstract] [Full Text] [Related]
2. Vaginal and cervical abnormalities after exposure to stilbestrol in utero.
Herbst AL; Kurman RJ; Scully RE
Obstet Gynecol; 1972 Sep; 40(3):287-98. PubMed ID: 5054957
[No Abstract] [Full Text] [Related]
3. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
Int Surg; 1977 Mar; 62(3):152-5. PubMed ID: 852937
[No Abstract] [Full Text] [Related]
4. Stilboestrol and human cancer.
Bishun NP; Smith NS; Williams DC
Clin Oncol; 1977 Mar; 3(1):75-80. PubMed ID: 862278
[No Abstract] [Full Text] [Related]
5. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
[TBL] [Abstract][Full Text] [Related]
6. Transplacental carcinogenesis by stilbestrol.
Folkman J
N Engl J Med; 1971 Aug; 285(7):404-5. PubMed ID: 5556579
[TBL] [Abstract][Full Text] [Related]
7. [The stilbestrol--adenosis--carcinoma--syndrome. A review].
Ulfelder H
Geburtshilfe Frauenheilkd; 1975 May; 35(5):329-33. PubMed ID: 1150064
[No Abstract] [Full Text] [Related]
8. Vaginal and cervical abnormalities, including clear-cell adenocarcinoma, related to prenatal exposure to stilbestrol.
Scully RE; Robboy SJ; Herbst AL
Ann Clin Lab Sci; 1974; 4(4):222-33. PubMed ID: 4460850
[TBL] [Abstract][Full Text] [Related]
9. Pathology of vaginal and cervical abnormalities associated with prenatal exposure to diethylstilbestrol (des).
Robboy SJ; Scully RE; Herbst AL
J Reprod Med; 1975 Jul; 15(1):13-18. PubMed ID: 1151939
[No Abstract] [Full Text] [Related]
10. Natural history of vaginal adenosis in women exposed to diethylstilbestrol in utero.
Ng AB; Reagan JW; Nadji M; Greening S
J Reprod Med; 1977 Jan; 18(1):1-13. PubMed ID: 833795
[No Abstract] [Full Text] [Related]
11. Post-stilbestrol secondary syndrome.
Pomerance W
Obstet Gynecol; 1973 Jul; 42(1):12-8. PubMed ID: 4720194
[No Abstract] [Full Text] [Related]
12. Cancer risk in DES-exposed offspring.
Powell JL
J Med Assoc Ga; 1979 May; 68(5):403-6. PubMed ID: 438682
[No Abstract] [Full Text] [Related]
13. [Transplacental carcinogenesis].
Napalkov NP
Vestn Akad Med Nauk SSSR; 1977; (10):14-9. PubMed ID: 411275
[No Abstract] [Full Text] [Related]
14. The Diethylstilbestrol (DES) exposed female in Maine. A discussion with suggestions regarding identification and management applicable to our state.
Zerner J; Wilkis JL; Fenn ME
J Maine Med Assoc; 1976 Jun; 67(6):163-5. PubMed ID: 932552
[No Abstract] [Full Text] [Related]
15. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
Barber HR; Sommers SC
Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
[No Abstract] [Full Text] [Related]
16. Vaginal and cervical cancers associated with exposure in utero to diethylstilbestrol.
J Med Soc N J; 1977 Jan; 74(1):68-70. PubMed ID: 264577
[No Abstract] [Full Text] [Related]
17. Vaginal adenocarcinoma in young women.
Lancet; 1971 May; 1(7709):1111-2. PubMed ID: 4102630
[No Abstract] [Full Text] [Related]
18. [Transplacental cancerogenic effect of stilbestrol].
Drobnjak B
Lijec Vjesn; 1973 Jul; 95(7):408-10. PubMed ID: 4590502
[No Abstract] [Full Text] [Related]
19. Summary of the changes in the human female genital tract as a consequence of maternal diethylstilbestrol therapy.
Herbst AL
J Toxicol Environ Health Suppl; 1976; 1():13-20. PubMed ID: 994230
[TBL] [Abstract][Full Text] [Related]
20. [Daughters of DES (diethylstilbestrol)].
Nishiya I
Hokkaido Igaku Zasshi; 1976 Jul; 51(4):357-8. PubMed ID: 793970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
